Studies have confirmed that the increased of immune checkpoints such as PD-L1, CTLA-4, TIM-3, and LAG3 in glioma helps tumor immune evasion, leading to T cell dysfunction (Xue et al., 2017; Woroniecka et al., 2018). Here, HAVCR2 is linked to central nervous system cancer.